In conclusion, given the strict interactions between HERVs, TRIM28, and SETDB1 and the immune system, our results may open new avenues of research focusing on retroviruses and epigenetic regulatory pathways not only to better understand the etiopathogenesis of allergy, but also as potential innovative diagnostic and therapeutic targets. This evidence concerns the gene TRIM28 and Allergy.